Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127078721 | 12707872 | 1 | I | 20160824 | 20160901 | 20160901 | EXP | PE-PFIZER INC-2016403697 | PFIZER | 77.00 | YR | F | Y | 0.00000 | 20160901 | CN | PE | PE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127078721 | 12707872 | 1 | PS | XALATAN | LATANOPROST | 1 | Ophthalmic | 1 GTT (ON EACH EYE), DAILY | 20597 | 1 | GTT | EYE DROPS, SOLUTION | |||||||
| 127078721 | 12707872 | 2 | C | ALLERGAN | PAPAIN | 1 | UNK | U | 0 | ||||||||||
| 127078721 | 12707872 | 3 | C | GLAUCOTENSIL /00971201/ | 2 | UNK | U | 0 | |||||||||||
| 127078721 | 12707872 | 4 | C | VISCOTEARS | CARBOMER | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127078721 | 12707872 | 1 | Glaucoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127078721 | 12707872 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127078721 | 12707872 | Dry eye | |
| 127078721 | 12707872 | Intraocular pressure increased | |
| 127078721 | 12707872 | Product quality issue | |
| 127078721 | 12707872 | Vulval cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127078721 | 12707872 | 1 | 2014 | 0 |